Thank you for visiting www.solx.com. If you searched for this web site because of an interest in the treatment of glaucoma, we hope you will find the information contained on our site to be valuable.

Advances in the surgical treatment of glaucoma have the potential to change the way patients with glaucoma are treated. SOLX® provides a powerful new set of tools that have the potential to change the way primary open-angle glaucoma is treated. The SOLX Glaucoma Treatment System is the first multiple approach platform of technologies designed to lower intraocular pressure (IOP) without a bleb, thereby reducing or eliminating bleb-related complications and the need for multiple medications. The Glaucoma Treatment System is comprised of the SOLX® Gold Shunt implant, the SOLX® 790 Laser for trabeculoplasty and the SOLX IOP Sensor, a device designed to continuously monitor IOP. These devices are designed to work individually or as a combination therapy.

SOLX commenced commercial operations in 2000 and spent the following four years in research and product development at Boston University’s Photonics Center Business Acceleration Program.

 

Features of the SOLX Glaucoma Treatment System:

• The Gold Shunt is the only shunt designed to reduce elevated IOP in the eye by connecting the anterior chamber and suprachoroidal space.
• The 790 Laser penetrates deeper than lasers currently used in trabeculoplasty, and may lead to longer-lasting treatment benefits.
• Both the 790 Laser and the Gold Shunt provide physicians with a new level of control in the treatment of glaucoma.
• Both are consistent with treatment methods that are already familiar to physicians.
• Both are capable of reducing side effects and costs associated with using multiple medications.

 

SYSTEM COMPONENTS

The SOLX Gold Shunt

The SOLX Gold Shunt is a sterile, multi-channeled, valveless, flat drainage device designed for implantation between the anterior chamber and suprachoroidal space of the eye. The ultra-thin implant is fabricated from biocompatible 24 karat 99.95% gold, and has a number of small channels that directs significant aqueous flow to the suprachoroidal space.

The SOLX 790 Laser

The SOLX 790 Laser is a solid-state Titanium:Sapphire Laser that performs Laser Trabeculoplasty, a glaucoma treatment used to lower the intraocular pressure of the eye.  Its near-infrared 790nm wavelength penetrates deeply into the tissues of the Trabecular Meshwork without causing significant amounts of thermal, coagulative, or biodestructive damage unlike other ophthalmic laser platforms.

The SOLX IOP Sensor

The SOLX IOP Sensor is an implantable sensor designed for continuous monitoring of IOP. The device was prototyped at Purdue Brain-Computer Interface (BCI) Lab. The device is expected to enter human clinical trials in the US in 2009.

CONTACT

For more information, please contact Doug Adams, at 978-808-6926 or doug@solx.com or visit SOLX online at www.solx.com.

Learn More About SOLX:

• Company Bios
• Message from the President